SHOCK, CARDIOGENIC
Clinical trials for SHOCK, CARDIOGENIC explained in plain language.
Never miss a new study
Get alerted when new SHOCK, CARDIOGENIC trials appear
Sign up with your email to follow new studies for SHOCK, CARDIOGENIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a smartphone app and smart blood pressure cuff save heart shock patients?
Disease control Recruiting nowThis study tests whether a digital platform that monitors blood pressure and symptoms at home can improve outcomes for people with early cardiogenic shock, a serious heart condition. About 472 patients will be split into two groups: one gets standard discharge care, the other get…
Matched conditions: SHOCK, CARDIOGENIC
Phase: NA • Sponsor: Renmin Hospital of Wuhan University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Do Heart-Strengthening drugs actually help in shock? major trial aims to find out
Disease control Recruiting nowThis study tests whether drugs that increase the heart's pumping ability (inotropes) benefit patients in cardiogenic shock, a life-threatening condition where the heart can't pump enough blood. About 346 critically ill adults will receive either dobutamine, milrinone, or a placeb…
Matched conditions: SHOCK, CARDIOGENIC
Phase: PHASE4 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New antibody drug targets deadly heart shock in early trial
Disease control Recruiting nowThis early-stage trial tests a new antibody drug called procizumab in 130 people with cardiogenic shock, a life-threatening condition where the heart cannot pump enough blood. The drug blocks a protein called DPP3, which is linked to worse outcomes. The main goal is to check safe…
Matched conditions: SHOCK, CARDIOGENIC
Phase: PHASE1, PHASE2 • Sponsor: 4TEEN4 Pharmaceuticals GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC